Molecular Signature Used To Predict Radiation Therapy Benefit Validated By Moffitt Ca

tD33NAt

Active member
Joined
Mar 24, 2008
Messages
12,519
Reaction score
0
Points
36
Researchers at Moffitt Cancer Center, working with colleagues in Sweden, the Netherlands and Puerto Rico, have validated a radiosensitivity molecular signature that can lead to better radiation therapy decisions for treating patients with breast cancer. The results appeared in a recent issue of Clinical Cancer Research, a publication of the American Association for Cancer Research...
mD_zt8uM7O8


More...
 
Back
Top